Journal of Shanghai Jiao Tong University (Medical Science) >

2021 , Vol. 41 >Issue 3: 371 - 375

DOI: https://doi.org/10.3969/j.issn.1674-8115.2021.03.015

Review

Physiological function of cholesterol sulfate and its role in related diseases

  • Yue-ting JIANG ,
  • Jia-ying NI ,
  • Shen-rui GUO ,
  • Han LI ,
  • Yu-jia ZHUANG ,
  • Feng WANG
Expand
  • 1.Department of Immunology and Microbiology, Shanghai Jiao Tong University College of Basic Medicine Sciences, Shanghai 200025, China
    2.Shanghai Jiao Tong University, Shanghai Institute of Immunology, Shanghai 200025, China

Received date: 2020-02-17

  Online published: 2021-04-06

Supported by

National Key Research and Development Program of China(SQ2018YFA090045-01);National Natural Science Foundation of China(81771739);Basic Research Project of Shanghai Municipal Commission of Science and Technology(18JC1414100);Innovative Research Team of High-Level Local Universities in Shanghai(SSMU-ZDCX20180101)

Fold

Abstract

Cholesterol sulfate (CS), synthesized by sulfotransferase (SULT) 2B1b, is an important steroid sulfate and plays important physiological roles in the human body. It is widely distributed in human body, such as skin, adrenal gland, liver, lung, brain and endometrium. CS participates in the formation of cornified envelopes and the expression of keratinocyte differentiation markers in the epidermis, thereby regulating epidermal desquamation and barrier function. CS inhibits T cell signaling during thymocyte development in the immune system, and CS/ Cholesterol ratio directly affects thymic selection for T cells, thereby participating in the shaping of T cell receptor repertoire. CS regulates brain metabolism and exerts neuroprotective effects by reducing oxidative stress, maintaining mitochondrial membrane stability and increasing energy reserves. In addition, CS also contributes to the development of many diseases by regulating the activity of functional proteins. The deletion and mutation of steroid sulfatase (STS) gene, which catalyzes the desulfurization of CS, directly leads to the occurrence of X-linked ichthyosis. CS is involved in the development of Alzheimer's disease by promoting the aggregation of amyloid β - protein (Aβ). CS regulates gluconeogenesis by inhibiting the activation of hepatocyte nuclear factor 4α (HNF4α). Thus CS is expected to treat type 2 diabetes. CS has abnormal expression in a variety of cancers, and can interact with matrix metalloproteinase-7 (MMP-7) to induce the aggregation and metastasis of cancer cells. The main challenges and research priorities at this stage are to reveal specific molecular mechanisms under different physiological and pathological conditions and to design feasible clinical treatments.

Key words： cholesterol sulfate (CS); keratinocyte; T cell signaling; glycometabolism; cancer

Cite this article

Yue-ting JIANG , Jia-ying NI , Shen-rui GUO , Han LI , Yu-jia ZHUANG , Feng WANG . Physiological function of cholesterol sulfate and its role in related diseases[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2021 , 41(3) : 371 -375 . DOI: 10.3969/j.issn.1674-8115.2021.03.015

References

1 National Center for Biotechnology Information. PubChem Compound Summary for CID65076, Cholesterol sulfate[EB/OL].[2021-01-02]..
2 Koizumi M, Momoeda M, Hiroi H, et al. Expression and regulation of cholesterol sulfotransferase (SULT2B1b) in human endometrium[J]. Fertil Steril, 2010, 93(5): 1538-1544.
3 Zenri F, Hiroi H, Momoeda M, et al. Expression of retinoic acid-related orphan receptor α and its responsive genes in human endometrium regulated by cholesterol sulfate[J]. J Steroid Biochem Mol Biol, 2012, 128(1/2): 21-28.
4 Prah J, Winters A, Chaudhari K, et al. Cholesterol sulfate alters astrocyte metabolism and provides protection against oxidative stress[J]. Brain Res, 2019, 1723: 146378.
5 Strott CA, Higashi Y. Cholesterol sulfate in human physiology: what's it all about?[J]. J Lipid Res, 2003, 44(7): 1268-1278.
6 Sánchez-Guijo A, Oji V, Hartmann MF, et al. Simultaneous quantification of cholesterol sulfate, androgen sulfates, and progestagen sulfates in human serum by LC-MS/MS[J]. J Lipid Res, 2015, 56(9): 1843-1851.
7 Elias PM, Williams ML, Choi EH, et al. Role of cholesterol sulfate in epidermal structure and function: lessons from X-linked ichthyosis[J]. Biochim Biophys Acta, 2014, 1841(3): 353-361.
8 Nagata K, Yamazoe Y. Pharmacogenetics of sulfotransferase[J]. Annu Rev Pharmacol Toxicol, 2000, 40: 159-176.
9 Her C, Wood TC, Eichler EE, et al. Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene[J]. Genomics, 1998, 53(3): 284-295.
10 Eckhart L, Tschachler E, Gruber F. Autophagic control of skin aging[J]. Front Cell Dev Biol, 2019, 7: 143.
11 Eckhart L, PLJMZeeuwen. The skin barrier: epidermis vs environment[J]. Exp Dermatol, 2018, 27(8): 805-806.
12 Feingold KR, Jiang YJ. The mechanisms by which lipids coordinately regulate the formation of the protein and lipid domains of the stratum corneum: role of fatty acids, oxysterols, cholesterol sulfate and ceramides as signaling molecules[J]. Dermatoendocrinol, 2011, 3(2): 113-118.
13 Hanley K, Wood L, Ng DC, et al. Cholesterol sulfate stimulates involucrin transcription in keratinocytes by increasing Fra-1, Fra-2, and Jun D[J]. J Lipid Res, 2001, 42(3): 390-398.
14 Denning MF, Kazanietz MG, Blumberg PM, et al. Cholesterol sulfate activates multiple protein kinase C isoenzymes and induces granular cell differentiation in cultured murine keratinocytes[J]. Cell Growth Differ, 1995, 6(12): 1619-1626.
15 Kawabe S, Ikuta T, Ohba M, et al. Cholesterol sulfate activates transcription of transglutaminase 1 gene in normal human keratinocytes[J]. J Invest Dermatol, 1998, 111(6): 1098-1102.
16 Kuroki T, Ikuta T, Kashiwagi M, et al. Cholesterol sulfate, an activator of protein kinase C mediating squamous cell differentiation: a review[J]. Mutat Res, 2000, 462(2/3): 189-195.
17 Hanyu O, Nakae H, Miida T, et al. Cholesterol sulfate induces expression of the skin barrier protein filaggrin in normal human epidermal keratinocytes through induction of RORα[J]. Biochem Biophys Res Commun, 2012, 428(1): 99-104.
18 Presland RB. Function of filaggrin and caspase-14 in formation and maintenance of the epithelial barrier[J]. Dermatol Sinica, 2009, 27: 1-14.
19 Wang F, Beck-García K, Zorzin C, et al. Inhibition of T cell receptor signaling by cholesterol sulfate, a naturally occurring derivative of membrane cholesterol[J]. Nat Immunol, 2016, 17(7): 844-850.
20 Ivanisevic J, Epstein AA, Kurczy ME, et al. Brain region mapping using global metabolomics[J]. Chem Biol, 2014, 21(11): 1575-1584.
21 Diociaiuti A, Angioni A, Pisaneschi E, et al. X-linked ichthyosis: clinical and molecular findings in 35 Italian patients[J]. Exp Dermatol, 2019, 28(10): 1156-1163.
22 郑晓草, 王剑巧, 曹先伟. X-连锁鱼鳞病[J]. 皮肤科学通报, 2020, 37(1): 36-41.
23 Fernandes NF, Janniger CK, Schwartz RA. X-linked ichthyosis: an oculocutaneous genodermatosis[J]. J Am Acad Dermatol, 2010, 62(3): 480-485.
24 Ca?ueto J, Ciria S, Hernández-Martín A, et al. Analysis of the STS gene in 40 patients with recessive X-linked ichthyosis: a high frequency of partial deletions in a Spanish population[J]. J Eur Acad Dermatol Venereol, 2010, 24(10): 1226-1229.
25 Elias PM, Williams ML, Feingold KR. Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders[J]. Clin Dermatol, 2012, 30(3): 311-322.
26 Kelly JW. Alternative conformations of amyloidogenic proteins govern their behavior[J]. Curr Opin Struct Biol, 1996, 6(1): 11-17.
27 沈怡君. Aβ蛋白在阿尔兹海默病中的损伤机制以及研究进展[J]. 中国实用神经疾病杂志, 2015, 18(1): 127-129.
28 di Paolo G, Kim TW. Linking lipids to Alzheimer's disease: cholesterol and beyond[J]. Nat Rev Neurosci, 2011, 12(5): 284-296.
29 Elbassal EA, Liu HY, Morris C, et al. Effects of charged cholesterol derivatives on Aβ40 amyloid formation[J]. J Phys Chem B, 2016, 120(1): 59-68.
30 Bi YH, Shi XJ, Zhu JJ, et al. Regulation of cholesterol sulfotransferase SULT2B1b by hepatocyte nuclear factor 4α constitutes a negative feedback control of hepatic gluconeogenesis[J]. Mol Cell Biol, 2018, 38(7): e00654-17.
31 Shi XJ, Cheng QQ, Xu LY, et al. Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4α[J]. Mol Cell Biol, 2014, 34(3): 485-497.
32 Paine MRL, Kim J, Bennett RV, et al. Whole reproductive system non-negative matrix factorization mass spectrometry imaging of an early-stage ovarian cancer mouse model[J]. PLoS One, 2016, 11(5): e0154837.
33 Johnson CH, Santidrian AF, LeBoeuf SE, et al. Metabolomics guided pathway analysis reveals link between cancer metastasis, cholesterol sulfate, and phospholipids[J]. Cancer Metab, 2017, 5: 9.
34 Turanli B, Karagoz K, Bidkhori G, et al. Multi-omic data interpretation to repurpose subtype specific drug candidates for breast cancer[J]. Front Genet, 2019, 10: 420.
35 Yang J, Broman MM, Cooper PO, et al. Distinct expression patterns of SULT2B1b in human prostate epithelium[J]. Prostate, 2019, 79(11): 1256-1266.
36 Park S, Song CS, Lin CL, et al. Inhibitory interplay of SULT2B1b sulfotransferase with AKR1C3 aldo-keto reductase in prostate cancer[J]. Endocrinology, 2020, 161(2): bqz042.
37 Vickman RE, Crist SA, Kerian K, et al. Cholesterol sulfonation enzyme, SULT2B1b, modulates AR and cell growth properties in prostate cancer[J]. Mol Cancer Res, 2016, 14(9): 776-786.
38 Vickman RE, Yang J, Lanman NA, et al. Cholesterol sulfotransferase SULT2B1b modulates sensitivity to death receptor ligand TNFα in castration-resistant prostate cancer[J]. Mol Cancer Res, 2019, 17(6): 1253-1263.
39 Yang XM, Du XC, Sun L, et al. SULT2B1b promotes epithelial-mesenchymal transition through activation of the β-catenin/MMP7 pathway in hepatocytes[J]. Biochem Biophys Res Commun, 2019, 510(4): 495-500.
40 Hu L, Yang GZ, Zhang Y, et al. Overexpression of SULT2B1b is an independent prognostic indicator and promotes cell growth and invasion in colorectal carcinoma[J]. Lab Invest, 2015, 95(9): 1005-1018.
41 Hong WT, Guo FH, Yang MJ, et al. Hydroxysteroid sulfotransferase 2B1 affects gastric epithelial function and carcinogenesis induced by a carcinogenic agent[J]. Lipids Health Dis, 2019, 18(1): 203.
42 Hu RK, Huffman KE, Chu M, et al. Quantitative secretomic analysis identifies extracellular protein factors that modulate the metastatic phenotype of non-small cell lung cancer[J]. J Proteome Res, 2016, 15(2): 477-486.
43 Samukange V, Yasukawa K, Inouye K. Effects of heparin and cholesterol sulfate on the activity and stability of human matrix metalloproteinase 7[J]. Biosci Biotechnol Biochem, 2014, 78(1): 41-48.
44 Yamamoto K, Miyazaki K, Higashi S. Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin[J]. J Biol Chem, 2010, 285(37): 28862-28873.
45 Yamamoto K, Miyazaki K, Higashi S. Pericellular proteolysis by matrix metalloproteinase-7 is differentially modulated by cholesterol sulfate, sulfatide, and cardiolipin[J]. FEBS J, 2014, 281(15): 3346-3356.
46 Prior SH, Fulcher YG, Koppisetti RK, et al. Charge-triggered membrane insertion of matrix metalloproteinase-7, supporter of innate immunity and tumors[J]. Structure, 2015, 23(11): 2099-2110.
47 Ishikawa T, Kimura Y, Hirano H, et al. Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1[J]. J Biol Chem, 2017, 292(50): 20769-20784.
Options
Outlines

/

〈 〉